Literature DB >> 8439651

Glomerular epithelial cells produce endothelin-1.

A V Cybulsky1, D J Stewart, M I Cybulsky.   

Abstract

Endothelin-1, a vasoactive peptide originally isolated from vascular endothelial cell culture supernatants, has constricting or mitogenic effects on smooth muscle and glomerular mesangial cells. Whether or not cultured rat glomerular epithelial cells synthesize endothelin-1 was assessed. Under basal culture conditions, the synthesis and release of endothelin-1 peptide by glomerular epithelial cells was time dependent, reaching 0.231 +/- 0.017 pg/1,000 cells at 24 h. For comparison, unstimulated bovine pulmonary artery endothelial cells and rat mesangial cells produced 0.982 +/- 0.237 and 0.004 +/- 0.002 pg of endothelin-1 peptide/1,000 cells per 24 h, respectively. In addition to endothelin-1 peptide, unstimulated glomerular epithelial cells expressed preproendothelin-1 mRNA. Transforming growth factor-beta, complement C5b-9, thrombin, and phorbol myristate acetate significantly enhanced endothelin-1 peptide synthesis in glomerular epithelial cells (45, 15, 55, and 25% above basal levels at 24 h, respectively), whereas epidermal growth factor had no effect. Thrombin and phorbol myristate acetate appeared to stimulate endothelin-1 peptide by activating protein kinase C, because the protein kinase inhibitor 1-(5-isoquinolinyl-sulfonyl)-3-methyl-piperazine abolished the thrombin- and phorbol myristate acetate-induced rise in endothelin-1 but had no effect on basal production. The stimulatory effect of thrombin was also markedly diminished in glomerular epithelial cells that had been depleted of protein kinase C by prolonged preincubation with a high dose of phorbol myristate acetate. Thus, glomerular epithelial cells may be an important source of endothelin-1, which might influence glomerular vasoconstriction or proliferation of target cells, particularly in the presence of proinflammatory molecules in the glomerulus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439651     DOI: 10.1681/ASN.V371398

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.

Authors:  Marina Morigi; Simona Buelli; Cristina Zanchi; Lorena Longaretti; Daniela Macconi; Ariela Benigni; Daniela Moioli; Giuseppe Remuzzi; Carla Zoja
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies.

Authors:  Marina Morigi; Simona Buelli; Stefania Angioletti; Cristina Zanchi; Lorena Longaretti; Carla Zoja; Miriam Galbusera; Sara Gastoldi; Peter Mundel; Giuseppe Remuzzi; Ariela Benigni
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

5.  Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.

Authors:  Ammar Habib; Malik A Al-Omari; Mahyar Khaleghi; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Thomas H Mosley; Stephen T Turner; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2010-07-15       Impact factor: 2.689

6.  Extracellular matrix modulates epidermal growth factor receptor activation in rat glomerular epithelial cells.

Authors:  A V Cybulsky; A J McTavish; M D Cyr
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 7.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

8.  Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.

Authors:  Jean F Regal; Jenna M Lund; Cameron R Wing; Kate M Root; Luke McCutcheon; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2019-07-18       Impact factor: 4.407

Review 9.  Endothelin and the podocyte.

Authors:  Matthias Barton; Pierre-Louis Tharaux
Journal:  Clin Kidney J       Date:  2012-02

Review 10.  Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition.

Authors:  Ariela Benigni; Simona Buelli; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2020-03-17       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.